Gavin Wood Adaptimmune Therapeutics PLC (ADAP) insider trading activity
Gavin Wood is Chief Financial Officer of Adaptimmune Therapeutics PLC. Currently has a direct ownership of 0 shares of ADAP, which is worth approximately $0. The most recent transaction as insider was on Sep 02, 2025, when has been sold 96,000 shares (Ordinary Shares with a nominal value of GBP0.001 per share) at a price of $0.01 per share, resulting in proceeds of $960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
100.0%
3M change
100.0%
12M change
Total Value Held
$0
Gavin Wood Transaction History
GW
Gavin Wood
Chief Financial Officer
Abingdon, X0